The effect of cytochalasin D and colcemid on noradrenaline release in the human neuroblastoma SH-SY5Y.
Danks
K
K
Institute for Cardiovascular Research, Leeds, UK.
Walker
J H
JH
Vaughan
P F
PF
D015638:Cytochalasin D / Q000494:pharmacology*; D003703:Demecolcine / Q000494:pharmacology*; D004789:Enzyme Activation; D005724:Ganglia / Q000187:drug effects* / Q000378:metabolism; D006801:Humans; D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins; D000076250:Myristoylated Alanine-Rich C Kinase Substrate; D009447:Neuroblastoma / Q000378:metabolism / Q000473:pathology; D009638:Norepinephrine / Q000378:metabolism*; D011493:Protein Kinase C / Q000378:metabolism; D011506:Proteins / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014407:Tumor Cells, Cultured
D047908:Intracellular Signaling Peptides and Proteins; D008565:Membrane Proteins; D011506:Proteins; D000076250:Myristoylated Alanine-Rich C Kinase Substrate; D015638:Cytochalasin D; D011493:Protein Kinase C; D013755:Tetradecanoylphorbol Acetate; D009638:Norepinephrine; D003703:Demecolcine